ePrints
Items where Author is "Lama, S"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 3.
Article
Chuang, Y-F, Wang, P-Y, Kumar, S, Lama, S, Lin, F, Lin, F-L and Liu, G 
ORCID: 0000-0003-3379-724X 2021
, 'Methods for in vitro CRISPR/CasRx-Mediated RNA Editing'
, Frontiers in Cell and Developmental Biology
, pp. 1-13
, doi: https://doi.org/10.3389/fcell.2021.667879.
ORCID: 0000-0003-3379-724X 2021
, 'Methods for in vitro CRISPR/CasRx-Mediated RNA Editing'
, Frontiers in Cell and Developmental Biology
, pp. 1-13
, doi: https://doi.org/10.3389/fcell.2021.667879.
Wang, J-H, Tseng, C-L, Lin, F-L, Chen, J, Hsieh, E-H, Lama, S, Chuang, Y-F, Kumar, S, Zhu, L, McGuinness, MB, Hernandez, J, Tu, L, Wang, P-Y and Liu, G-S ORCID: 0000-0003-3379-724X 2022
, 'Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization'
, Theranostics, vol. 12, no. 2
, pp. 657-674
, doi: https://doi.org/10.7150/thno.65098.
ORCID: 0000-0003-3379-724X 2022
, 'Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization'
, Theranostics, vol. 12, no. 2
, pp. 657-674
, doi: https://doi.org/10.7150/thno.65098.
Zhu, L, Lama, S, Tu, L, Dusting, GJ, Wang, J-H and Liu, G ORCID: 0000-0003-3379-724X 2021
, 'TAK1 signaling is a potential therapeutic target for pathological angiogenesis'
, Angiogenesis
, doi: https://doi.org/10.1007/s10456-021-09787-5.
ORCID: 0000-0003-3379-724X 2021
, 'TAK1 signaling is a potential therapeutic target for pathological angiogenesis'
, Angiogenesis
, doi: https://doi.org/10.1007/s10456-021-09787-5.